Sign in
4

Changes in Ownership

Wave Life Sciences, Inc. Filed Acc 0000899243-23-005562

Chief Financial Officer sold 9,729 shares at $4.04 ($39,305)

From the SEC's structured data for this filing

Trades in this filing

Moran Kyle · Chief Financial Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2023-02-16 Sale : show line 1 in the form −9,729 $4.04 $39,305 79,751 D
Open-market sales · 9,729 sh · avg $4.04 · $39,305

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2023-02-17 Grant or award : show line 2 in the form Share Option (right to buy) +272,700 272,700 D
Loading xslF345X03/doc4.xml…